Novogene Co., Ltd. (SHA:688315)
19.39
+0.37 (1.95%)
Sep 23, 2026, 3:00 PM CST
Novogene Employees
Novogene had 2,227 employees as of June 30, 2026. The number of employees increased by 2 or 0.09% since the number was reported on December 31, 2025.
Employees
2,227
Change
2
Growth
0.09%
Revenue / Employee
1.03M CNY
Profits / Employee
67.96K CNY
Market Cap
7.87B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 2,227 | 2 | 0.09% |
| Dec 31, 2025 | 2,225 | 23 | 1.04% |
| Dec 31, 2024 | 2,202 | 58 | 2.71% |
| Dec 31, 2023 | 2,144 | -25 | -1.15% |
| Dec 31, 2021 | 2,169 | 178 | 8.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aurisco Pharmaceutical | 2,026 |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1,947 |
| Vcanbio Cell & Gene Engineering Corp., | 1,935 |
| Liaoning Chengda Biotechnology | 1,585 |
| Daan Gene | 1,506 |
| Bio-Thera Solutions | 1,471 |
| PharmaResources (Shanghai) | 1,297 |
| Beijing Hotgen Biotech | 1,043 |